VCA Inc (WOOF) was Reiterated by Stifel to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 75 from a previous price target of $68 . Stifel advised their investors in a research report released on Apr 28, 2016.
Many Wall Street Analysts have commented on VCA Inc. VCA Inc was Initiated by CL King to “Buy” on Apr 1, 2016. VCA Inc was Initiated by Credit Suisse to “Outperform” on Feb 4, 2016.
On the company’s financial health, VCA Inc reported $0.66 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 27, 2016. Analyst had a consensus of $0.61. The company had revenue of $563.44 million for the quarter, compared to analysts expectations of $558.10 million. The company’s revenue was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.50 EPS.
VCA Inc opened for trading at $63 and hit $64.98 on the upside on Wednesday, eventually ending the session at $64.74, with a gain of 5.51% or 3.38 points. The heightened volatility saw the trading volume jump to 16,79,482 shares. Company has a market cap of $5,229 M.
In a different news, on Sep 15, 2015, Josh Drake (President, Antech Diagnostics) sold 14,561 shares at $56.02 per share price.
VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company’s animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company’s communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company’s network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.